{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:10:32Z","timestamp":1758845432667,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10157-025-02743-3","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:19:23Z","timestamp":1757348363000},"page":"1465-1475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of renal effects between sacubitril\/valsartan and thiazide diuretics among patients with uncontrolled hypertension and chronic kidney disease in Japan"],"prefix":"10.1007","volume":"29","author":[{"given":"Mari","family":"Sotozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-9728","authenticated-orcid":false,"given":"Kazuo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinao","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Furuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hareaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Togo","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"6","key":"2743_CR1","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100.","journal-title":"Kidney Int"},{"issue":"1","key":"2743_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.ki.5002273","volume":"72","author":"PE Stevens","year":"2007","unstructured":"Stevens PE, O\u2019Donoghue DJ, De Lusignan S, Van Vlymen J, Klebe B, Middleton R, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72(1):92\u20139.","journal-title":"Kidney Int"},{"issue":"10","key":"2743_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/hr.2011.96","volume":"34","author":"M Nakayama","year":"2011","unstructured":"Nakayama M, Sato T, Miyazaki M, Matsushima M, Sato H, Taguma Y, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res. 2011;34(10):1106\u201310.","journal-title":"Hypertens Res"},{"issue":"9","key":"2743_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrneph.2015.114","volume":"11","author":"RR Townsend","year":"2015","unstructured":"Townsend RR, Taler SJ. Management of hypertension in chronic kidney disease. Nat Rev Nephrol. 2015;11(9):555\u201363.","journal-title":"Nat Rev Nephrol"},{"key":"2743_CR5","unstructured":"nephrology JSo. Evidence-based Clinical practice Guideline for CKD 2018 edited by Japanese Society of Nephrology. Nihon Jinzo Gakkai Shi. 2018;60(8)(Tokyo igakusha)."},{"issue":"9","key":"2743_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2743_CR7","unstructured":"Miyazawa MF, Y. Sato, H. Miyazaki, M. Matsushima, M Nakayama, M. Ito, S. Blood pressure management in CKD patients ; Miyagi Gonryou CKD study. Japanese Journal of Nephrology. 2011;53(3):356."},{"key":"2743_CR8","unstructured":"nephrology Jso. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012. Tokyo igakusha. 2012:5\u20136."},{"issue":"1","key":"2743_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41440-024-01989-w","volume":"48","author":"MK Jangid","year":"2025","unstructured":"Jangid MK, Doshi GM. Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management. Hypertens Res. 2025;48(1):284\u2013300.","journal-title":"Hypertens Res"},{"key":"2743_CR10","doi-asserted-by":"crossref","unstructured":"Kobayashi K SM, Chin K, Shimura H, Chiba K, Ito S, Tsuge T, Sakai H, Furuki T, Matsuzaki A, NakajimaA, TakadaT, Yamamoto H, Takeda H, Wakui H, Iwasawa T, Aoyama T, Toyoda M, Tamura K, Kanamori A. Comparison between sacubitril\/valsartan and thiazide diuretics among patients with uncontrolled hypertension in Japan. Hypertension Research. 2025;ahead of print.","DOI":"10.1038\/s41440-025-02236-6"},{"key":"2743_CR11","unstructured":"Kobayashi K CK, Furuki T, Sakai H, Miyakawa M, Asayama K, Eguchi N, Katsuya T, Sato K, Tamura K, Kanamori A. Cross-sectional survey of hypertension management among patients stratified by chronic kidney disease in Japan. JMA journal. 2025:in press."},{"issue":"4","key":"2743_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37(4):253\u2013390.","journal-title":"Hypertens Res"},{"issue":"6","key":"2743_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2743_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/M20-0529","volume":"173","author":"K Sumida","year":"2020","unstructured":"Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis\u202f: an individual participant-based meta-analysis. Ann Intern Med. 2020;173(6):426\u201335.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2743_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.jhh.1001307","volume":"16","author":"T Tanaka","year":"2002","unstructured":"Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97\u2013103.","journal-title":"J Hum Hypertens"},{"key":"2743_CR16","doi-asserted-by":"crossref","unstructured":"Rubin DB. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons. 1987.","DOI":"10.1002\/9780470316696"},{"issue":"4","key":"2743_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/hr.2015.1","volume":"38","author":"S Ito","year":"2015","unstructured":"Ito S, Satoh M, Tamaki Y, Gotou H, Charney A, Okino N, et al. Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res. 2015;38(4):269\u201375.","journal-title":"Hypertens Res"},{"key":"2743_CR18","unstructured":"Kinguchi S IK, Wakui H, Tamura K. Switching from ARBs to ARNI safely improves 24-hour ambulatory BP in patients with advanced CKD. Am J Hypertens. 2025;ahead of print."},{"issue":"12","key":"2743_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41371-023-00851-9","volume":"37","author":"R Mitsuno","year":"2023","unstructured":"Mitsuno R, Uchiyama K, Nakayama T, Takahashi R, Yoshimoto N, Yamaguchi S, et al. Comparison of the effects of angiotensin receptor-neprilysin inhibitors and thiazide diuretic\/renin-angiotensin system inhibitor combination therapy in hypertensive patients: a retrospective cohort study. J Hum Hypertens. 2023;37(12):1049\u201355.","journal-title":"J Hum Hypertens"},{"issue":"27","key":"2743_CR20","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","volume":"385","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, et al. Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med. 2021;385(27):2507\u201319.","journal-title":"N Engl J Med"},{"issue":"8","key":"2743_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029565","volume":"12","author":"S Tsukamoto","year":"2023","unstructured":"Tsukamoto S, Uehara T, Azushima K, Wakui H, Tamura K. Updates for cardio-kidney protective effects by angiotensin receptor-neprilysin inhibitor: requirement for additional evidence of kidney protection. J Am Heart Assoc. 2023;12(8): e029565.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2743_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1159\/000541939","volume":"49","author":"E Hishida","year":"2024","unstructured":"Hishida E, Nagata D. Angiotensin receptor-neprilysin inhibitor for chronic kidney disease: strategies for renal protection. Kidney Blood Press Res. 2024;49(1):916\u201332.","journal-title":"Kidney Blood Press Res"},{"issue":"12","key":"2743_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10157-024-02561-z","volume":"28","author":"Y Saka","year":"2024","unstructured":"Saka Y, Takahashi H, Naruse T, Watanabe Y. Sacubitril\/valsartan reduces proteinuria depending on blood pressure in patients with stage 4\u20135 chronic kidney disease. Clin Exp Nephrol. 2024;28(12):1327\u201331.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2743_CR24","first-page":"489","volume":"6","author":"K Damman","year":"2018","unstructured":"Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, et al. Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC: Heart Failure. 2018;6(6):489\u201398.","journal-title":"JACC: Heart Failure"},{"issue":"15","key":"2743_CR25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.118.034818","volume":"138","author":"R Haynes","year":"2018","unstructured":"Haynes R, Judge PK, Staplin N, Herrington WG, Storey BC, Bethel A, et al. Effects of sacubitril\/valsartan versus irbesartan in patients with chronic kidney disease. Circulation. 2018;138(15):1505\u201314.","journal-title":"Circulation"},{"issue":"8","key":"2743_CR26","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2014070688","volume":"26","author":"HJ Lambers Heerspink","year":"2015","unstructured":"Lambers Heerspink HJ, Kr\u00f6pelin TF, Hoekman J, De Zeeuw D. Drug-induced reduction in albuminuria is associated with subsequent renoprotection. J Am Soc Nephrol. 2015;26(8):2055\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2743_CR27","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2019010007","volume":"30","author":"LA Inker","year":"2019","unstructured":"Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, et al. Gfr slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials. J Am Soc Nephrol. 2019;30(9):1735\u201345.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02743-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02743-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02743-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:37:28Z","timestamp":1758789448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02743-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2743"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02743-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mari Sotozawa, Kyoji Chiba, Kazuo Kobayashi, Keiichi Chin, Hideo Shimura, Toshinao Tsuge, Shun Ito, Hiroyuki Sakai, Takayuki Furuki, Atsushi Matsuzaki, Shinichi Nakajima, Nobukazu Takada, Hareaki Yamamoto, Hiroshi Takeda, Takamasa Iwasawa, Togo Aoyama, and Akira Kanamori declare no conflict of interest. Hiromichi Wakui has received research supports from AstraZeneca, Otsuka Pharmaceutical, and Kaneka Corporation, and honoraria from AstraZeneca, Otsuka Pharmaceutical, Kaneka Corporation, Kyowa Kirin, Sanwa Kagaku, Chugai Pharma, Kowa, Otsuka Pharmaceutical, Novartis, Mitsubishi Tanabe Pharma, Bayer, and Daiichi-Sankyo Pharma. Masao Toyoda received lecture fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sumitomo, and Mitsubishi Tanabe and received subsidies from Super Light Water, TAKAGI, Roche DC, and LifeScan. Kouichi Tamura has received honoraria\/lecture fee from AstraZeneca, Novartis, Bayer, Otsuka Pharmaceutical, Boehringer Ingelheim, Fuji Pharma, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku, Mochida Pharmaceutical, Kowa, Eli Lilly, and Novo Nordisk; commissioned clinical trials, contract research, and joint research funding from AstraZeneca, Bayer, Novartis, Chinook, Otsuka Medical Devices, Novo Nordisk, Terumo, Viatris, and Kowa, and received scholarship donations from Otsuka Pharmaceutical, Bayer, Mochida Pharmaceutical, and Boehringer Ingelheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Review Board of the Kanagawa Medical Association, Kanagawa Prefecture, Japan (krec2305, approval on December 18, 2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval date of registry and the registration no. of the study\/trial"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}